| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |